Thrombosis Research
Volume 126, Issue 2 , Pages 130-136 , August 2010

A potential regulatory role for mRNA secondary structures within the prothrombin 3'UTR

  • Xingge Liu

      Affiliations

    • Current address: Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104.
    • ,
  • Yong Jiang

      Affiliations

    • Current address: GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA 19426.
    • ,
  • J. Eric Russell

      Affiliations

    • Corresponding Author InformationCorresponding author. Abramson Research Building, Room 310D, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104. Tel.: +1 215 590 3880; fax: +1 215 590 2320.

Received 10 March 2010 ,Revised 10 March 2010 ,Accepted 20 April 2010.

References 

  1. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057–1068
  2. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, et al. Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet. 2001;28:389–392
  3. Ceelie H. Spaargaren-van Riel CC, Bertina RM, and Vos HL. G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3'-end formation. J Thromb Haemost. 2004;2:119–127
  4. Carter AM, Sachchithananthan M, Stasinopoulos S, Maurer F, Medcalf RL. Prothrombin G20210A is a bifunctional gene polymorphism. Thromb Haemost. 2002;87:846–853
  5. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698–3703
  6. Franco RF, Trip MD, ten Cate H, van den Ende A, Prins MH, Kastelein JJ, et al. The 20210 G->A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Brit J Heme. 1999;104:50–54
  7. Soria JM, Almasy L, Souto JC, Tirado I, Borell M, Mateo J, et al. Linkage analysis demonstrates that the prothrombotic G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood. 2000;95:2780–2785
  8. Hillarp A, Zoller B, Svensson PJ, Dahlback B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost. 1997;78:990–992
  9. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, et al. Prothrombin gene G20210->A transition is a risk factor for cerebral venous thrombosis. Stroke. 1998;29:1765–1769
  10. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793–1797
  11. Mercier E, Quere I, Campello C, Mares P, Gris JC. The 20210A allele of the prothrombin gene is frequent in young women with unexplained spinal cord infarction. Blood. 1998;92:1840–1841
  12. Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae, and second trimester loss. Acta Obstet Gynecol Scand. 2000;79:963–967
  13. Zoller B, Garcia de Frutos P, Hillarp A, Dahlback B. Thrombophilia as a multigenic disease. Haematologica. 1999;84:59–70
  14. Pollak ES, Lam H-S, Russell JE. The G20210A mutation does not affect the stability of prothrombin mRNA in vivo. Blood. 2002;100:359–362
  15. von Ahsen N, Oellerich M. The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system. Blood. 2004;103:586–593
  16. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CG. Proliferating cells express mRNAs with shortened 3'UTRs and fewer microRNA target sites. Science. 2008;320:1643–1647
  17. Shell SA, Hesse C, Morris SM, Milcarek C. Elevated levels of 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharide-stimulated macrophages influence gene expression and induce alternative poly(A) site selection. J Biol Chem. 2005;280:39950–39961
  18. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline responsive promoters. Proc Natl Acad Sci USA. 1992;89:5547–5551
  19. Jiang Y, Xu X-S, Russell JE. A nucleolin-binding 3'UTR element stabilizes [beta]-globin mRNA in vivo. Mol Cell Biol. 2006;26:2419–2429
  20. Russell JE, Liebhaber SA. The stability of human beta-globin mRNA is dependent on structural determinants positioned within its 3' untranslated region. Blood. 1996;87:5314–5323
  21. Yu J, Russell JE. Structural and functional analysis of an mRNP complex that mediates the high stability of human [beta]-globin mRNA. Mol Cell Biol. 2001;21:5879–5888
  22. Kong J, Ji X, Liebhaber SA. Mechanistic analysis of human [alpha]-globin mRNA stabilization. Blood. 2001;98:437a
  23. Weiss IM, Liebhaber SA. Erythroid cell-specific determinants of alpha-globin mRNA stability. Mol Cell Biol. 1994;14:8123–8132
  24. Fair DS, Bahnak BR. Human hepatoma cells secrete single chain factor X, prothrombin, and antithrombin III. Blood. 1984;64:194–204
  25. Huang MN, Hung HL, Stanfield-Oakley SA, High KA. Characterization of the human blood coagulation factor X promoter. J Biol Chem. 1992;267:15440–15446
  26. Mathews DH, Sabina J, Zucker M, Turner DH. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol. 1999;288:911–940
  27. Zucker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003;31:3406–3415
  28. Sengupta TK, Bandyopadhyay S, Fernandes DJ, Spicer EK. Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J Biol Chem. 2004;279:10855–10863
  29. Singh K, Laughlin J, Kosinski PA, Covey LR. Nucleolin is a second component of the CD154 mRNA stability complex that regulates mRNA turnover in activated T cells. J Immunol. 2004;173:976–985
  30. Ostareck-Lederer A, Ostareck DH, Vans C, Neubauer G, Bomsztyk K, Superti-Furga G, et al. c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol Cell Biol. 2002;22:4535–4543
  31. Yano M, Okano HJ, Okano H. Involvement of Hu and heterogeneous nuclear riboprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation. J Biol Chem. 2005;280:12690–12699
  32. Oberstrass FC, Auweter SD, Erat M, Hargous Y, Henning A, Wenter P, et al. Structure of PTB bound to RNA: specific binding and implications for splicing regulation. Science. 2005;309:2054–2057
  33. Perez I, Lin C-H, McAffee JG, Patton JG. Mutation of PTB-1 binding sites causes misregulation of alternative 3' splice site selection in vivo. RNA. 1997;3:764–768
  34. Danckwardt S, Kaufmann I, Gentzel M, Foerstner KU, Gantzert A-S, Gehring NH, et al. Splicing factors stimulate polyadenylation via USEs at non-canonical 3' end formation signals. EMBO J. 2007;26:2658–2669
  35. Danckwardt S, Gehring NH, Neu-Yilik G, Hundsdoerfer P, Pforsich M, Frede U, et al. The prothrombin 3'-end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations. Blood. 2004;104:428–435
  36. Pandey NB, Marzluff WF. The stem-loop structure at the 3' end of histone mRNA is necessary and sufficient for regulation of histone mRNA stability. Mol Cell Biol. 1987;7:4557–4559
  37. Klausner RD, Rouault TA, Harford JB. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell. 1993;72:19–28
  38. Zilka A, Garlapati S, Dahan E, Yaolsky V, Shapira M. Developmental regulation of heat shock protein 83 in Leishmania. 3' processing and mRNA stability control transcript abundance, and translation is directed by a determinant in the 3'-untranslated region. J Biol Chem. 2001;276:47922–47929
  39. Colgan DF, Manley JL. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 1997;11:2755–2766
  40. Bilenoglu O, Basak AN, Russell JE. A 3'UTR mutation affects [beta]-globin expression without altering the stability of its fully-processed mRNA. Br J Haematol. 2002;119:1106–1114
  41. Shaw G, Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 1986;46:659–667
  42. Holcik M, Liebhaber SA. Four highly stable eukaryotic mRNAs assemble 3'UTR RNA-protein complexes sharing cis- and trans-components. Proc Natl Acad Sci USA. 1997;94:2410–2414
  43. Pauws E, van Kampen AHC, van de Graaf SAR, de Vijlder JJM, Ris-Stalpers C. Heterogeneity in polyadenylation cleavage sites in mammalian mRNA sequences: implications for SAGE analysis. Nucleic Acids Res. 2001;29:1690–1694
  44. Tian B, Hu J, Zhang H, Lutz C. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 2005;33:201–212
  45. Beaudoing E, Gautheret D. Identification of alternate polyadenylation sites and analysis of their tissue distribution using EST data. Genome Res. 2001;11:1520–1526
  46. Kosinski PA, Laughlin J, Singh K, Covey LR. A complex containing polypyrimidine tract-binding protein is involved in regulating the stability of CD40 ligand (CD154) mRNA. J Immunol. 2003;170:979–988
  47. De Nova-Ocampo M, Villegas-Sepulveda N, del Angel RM. Translation elongation factor-1 alpha, La, and PTB interact with the 3' untranslated region of dengue 4 virus RNA. Virology. 2002;295:337–347
  48. Le Sommer C, Lesimple M, Mereau A, Menoret S, Allo M-R, Hardy S. PTB regulates the processing of a 3'-terminal exon by repressing both splicing and polyadenylation. Mol Cell Biol. 2005;25:9595–9607
  49. Castelo-Branco P, Furger A, Wollerton M, Smith C, Moreira A, Proodfoot N. Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol Cell Biol. 2004;24:4174–4183
  50. Hellen CU, Sarnow P. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 2001;15:1593–1612

PII: S0049-3848(10)00248-3

doi: 10.1016/j.thromres.2010.04.010

Thrombosis Research
Volume 126, Issue 2 , Pages 130-136 , August 2010

Article Tools

* Image Usage & Resolution